Cullgen Inc.
Company

Cullgen Inc.

Biotechnology Research 12730 High Bluff Dr 30 employees
Employees
30
Contacts
4
Emails
4
Phones
2

Cullgen Inc. Overview

Headquarters
12730 High Bluff Dr
Website
www.cullgen.com
Industry
Biotechnology Research
Employees
30
Founded
2018
Funding
35.0M
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Cullgen Inc.

Cullgen is a biopharmaceutical company that has developed protein degradation technology that utilizes the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Our technology, which we call uSMITE™ (ubiquitin-mediated, small molecule-induced target elimination) has the potential to address a broad range of intracellular disease targets, including those representing the up to 80% of proteins that cannot be addressed by existing small molecule therapies, commonly referred to as undruggable targets. In addition to using our uSMITE™ platform to build our own pipeline of protein degradation product candidates, we are also developing a portfolio of novel E3 ligands. You can learn more information about Cullgen on our website: www.Cullgen.com

Cullgen Inc. Contact Details

People in AeroLeads
4
With contact data
4
Email contacts
4
100.0% coverage
Phone contacts
2
50.0% coverage

Cullgen Inc. Org Chart

Sample employees and titles
Name Title Contact
S. Frank Yan
Email
Michael B Plewe
Email Phone
Jim Na
Email Phone
Thomas Eastling
Email

Compare Similar Companies to Cullgen Inc.